AstraZeneca accelerates cancer drug testing

LONDON (Reuters) - AstraZeneca has enrolled the first patient into a final-stage clinical trial of a new drug for a rare type of leukemia as the group's new CEO delivers on a promise to accelerate its oncology programs.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/wZ6Xxd7IPv0/story01.htm

project management certification phlebotomy training in birmingham al phlebotomy certification in tennessee